Učitavanje...

Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting

This article provides new insight on landiolol, an ultra-short acting injectable betablocker, recently approved in Europe, with regard to its pharmacokinetic and pharmacodynamic profile, along with its first experience in Caucasian healthy volunteers and patients with atrial fibrillation. Landiolol...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur Heart J Suppl
Glavni autori: Domanovits, Hans, Wolzt, Michael, Stix, Günter
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909771/
https://ncbi.nlm.nih.gov/pubmed/30188959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/sux037
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!